Barrett's Esophagus Clinical Trials

• DNA Changes as a Risk Factor for Barrett's Esophagus in Patients With Barrett's Esophagus, Gastroesophageal Reflux, or Gastrointestinal Bleeding
  ClinicalTrials.gov Identifier: NCT00445653 - Active, not recruiting
  Precancerous/Nonmalignant Condition
  
• Barrett's Esophagus & Gastroesophageal Reflux Disease
  ClinicalTrials.gov Identifier: NCT00513331 - Recruiting
  Barrett's Esophagus; GERD
  
• Acid Reflux and Stromal Fibroblasts in Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00573911 - Recruiting
  Barrett's Esophagus; GERD
  
• APE-Study: Ablation of Barrett's Mucosa vs. Surveillance Without Ablation in Patients Cured From Barrett's Cancer Combined With Randomization of Esomeprazole vs. Placebo for Symptomatic Reflux Control After Successful Barrett's Ablation
  ClinicalTrials.gov Identifier: NCT00546065 - Recruiting
  Barrett's Esophagus
  
• Confocal Endomicroscopy for Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00487695 - Recruiting
  Barrett's Esophagus; Esophageal Adenocarcinoma
  
• Familial Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00288119 - Recruiting
  Barrett's Esophagus; Esophageal Neoplasm
  
• Study of CryoSpray Ablation of Low Grade or High Grade Dysplasia Within Barrett's Esophagus.
  ClinicalTrials.gov Identifier: NCT00526786 - Recruiting
  Barrett's Esophagus
  
• Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
  ClinicalTrials.gov Identifier: NCT00574327 - Recruiting
  Barrett's Esophagus; Gastroesophageal Reflux Disease; Esophageal Adenocarcinoma
  
• An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients
  ClinicalTrials.gov Identifier: NCT00352261 - Completed
  Barrett's Esophagus
  
• Novel Imaging Techniques in Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00576498 - Recruiting
  Barrett Esophagus; Gastroesophageal Reflux
  
• Predicting Risk of Cancer in Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00431756 - Recruiting
  Barrett Esophagus; Esophageal Neoplasm; Gastroesophageal Reflux
  
• Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00386594 - Recruiting
  Barrett Esophagus
  
• Familial Aggregation of Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00058877 - Completed
  Barrett's Esophagus; Esophageal Neoplasm
  
• Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00321958 - Recruiting
  Barrett Esophagus; Esophageal Neoplasms; Deglutition Disorders; GERD; Neoplasm
  
• Ablation of Intestinal Metaplasia Containing Dysplasia
  ClinicalTrials.gov Identifier: NCT00282672 - Active, not recruiting
  Barrett's Esophagus
  
• Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial
  ClinicalTrials.gov Identifier: NCT00489268 - Completed
  Barrett's Esophagus
  
• Early Detection of Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00081354 - Recruiting
  Barrett Esophagus; Esophageal Diseases
  
• Studying Genes for Barrett's Esophagus in Brothers and Sisters
  ClinicalTrials.gov Identifier: NCT00516347 - Recruiting
  Esophageal Cancer; Precancerous/Nonmalignant Condition
  
• Optical Coherence Tomography of the Gastrointestinal Tract
  ClinicalTrials.gov Identifier: NCT00579748 - Active, not recruiting
  Barrett's Esophagus With or Without Dysplasia; Patients With Early Esophageal or Gastric Cancer; Patients With Intestinal Metaplasia of the Stomach
  
• Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00165490 - Active, not recruiting
  Adenocarcinoma of Esophagus; Squamous Cell Carcinoma of Esophagus
  
• Combination Chemotherapy, Radiation Therapy and Surgery in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00003087 - Active, not recruiting
  stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II esophageal cancer; squamous cell carcinoma of the esophagus
  
• Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00069953 - Active, not recruiting
  Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage II esophageal cancer; stage III esophageal cancer
  
• Biobank Esophagus Cancer: Storing Blood and Protein of Patients With Esophagus Cancer
  ClinicalTrials.gov Identifier: NCT00181337 - Recruiting
  Esophagus Cancer
  
• Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00003326 - Active, not recruiting
  stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent esophageal cancer; Quality of Life; squamous cell carcinoma of the esophagus
  
• Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00003118 - Active, not recruiting
  stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; stage II esophageal cancer; ...
  
• Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00002884 - Active, not recruiting
  childhood gastrointestinal cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; ...
  
• Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00066716 - Active, not recruiting
  Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage I esophageal cancer; stage II esophageal cancer; ...
  
• PNU-93914 in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00016900 - Active, not recruiting
  stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent esophageal cancer; Quality of Life; ...
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00002711 - Active, not recruiting
  stage III esophageal cancer; Adenocarcinoma of the Esophagus; recurrent esophageal cancer; stage I esophageal cancer; stage II esophageal cancer; ...
  
• Confocal Laserscanning Microscopy for Detection of Barretts Esophagus
  ClinicalTrials.gov Identifier: NCT00449995 - Recruiting
  Barrett Esophagus
  
• Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach
  ClinicalTrials.gov Identifier: NCT00004233 - Active, not recruiting
  Gastric Cancer; Esophageal Cancer; Adenocarcinoma of the Esophagus
  
• Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00030862 - Active, not recruiting
  stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer; squamous cell carcinoma of the esophagus; ...
  
• Cetuximab, Combination Chemotherapy, and Radiation therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00109850 - Active, not recruiting
  Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage III esophageal cancer
  
• Combination Chemotherapy and Interferon alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00004897 - Active, not recruiting
  squamous cell carcinoma of the esophagus; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; ...
  
• Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00107341 - Active, not recruiting
  Adenocarcinoma of the Esophagus; stage IV esophageal cancer; recurrent esophageal cancer
  
• Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00047112 - Active, not recruiting
  Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage I esophageal cancer; stage II esophageal cancer
  
• Endoscopic Therapy of Early Cancer in Barretts Esophagus
  ClinicalTrials.gov Identifier: NCT00217087 - Recruiting
  Early Stage Esophageal Adenocarcinoma; Barrett Esophagus
  
• Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer
  ClinicalTrials.gov Identifier: NCT00193128 - Recruiting
  Esophagus Cancer
  
• 3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00077545 - Active, not recruiting
  recurrent esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus
  
• Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00072033 - Active, not recruiting
  stage II esophageal cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus
  
• Radiation Therapy, Pemetrexed Disodium, and Carboplatin in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00268437 - Active, not recruiting
  Adenocarcinoma of the Esophagus; Squamous Cell Carcinoma of the Esophagus; Stage III Esophageal Cancer; Stage II Esophageal Cancer
  
• Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00006472 - Active, not recruiting
  stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; stage II esophageal cancer; ...
  
• Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00573131 - Recruiting
  Esophageal Cancer; Adenocarcinoma of the Esophagus; Squamous Cell Carcinoma of the Esophagus
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00014417 - Recruiting
  stage II esophageal cancer; stage III esophageal cancer; squamous cell carcinoma of the esophagus; Adenocarcinoma of the Esophagus
  
• Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00002897 - Active, not recruiting
  squamous cell carcinoma of the esophagus; stage III esophageal cancer; stage II esophageal cancer
  
• Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
  ClinicalTrials.gov Identifier: NCT00005607 - Active, not recruiting
  stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
  
• Radiation Therapy and Paclitaxel, Carboplatin, and Fluorouracil Followed by Esophagectomy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00022139 - Active, not recruiting
  stage III gastric cancer; stage II esophageal cancer; stage III esophageal cancer; adenocarcinoma of the stomach; ...
  
• Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00012363 - Active, not recruiting
  stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; recurrent esophageal cancer; adenocarcinoma of the stomach; ...
  
• Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00003487 - Recruiting
  stage IV esophageal cancer; recurrent esophageal cancer; Adenocarcinoma of the Esophagus
  
• Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00093652 - Active, not recruiting
  Adenocarcinoma of the Esophagus; recurrent esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; stage IV esophageal cancer; ...
  
• Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach
  ClinicalTrials.gov Identifier: NCT00003237 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage II esophageal cancer; ...
  
• Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00100945 - Active, not recruiting
  Adenocarcinoma of the Esophagus; stage II esophageal cancer
  
• Cetuximab in Treating Patients With Metastatic Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00096031 - Active, not recruiting
  Adenocarcinoma of the Esophagus; recurrent esophageal cancer; stage IV esophageal cancer
  
• Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00005878 - Completed
  Esophageal Cancer
  
• A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers.
  ClinicalTrials.gov Identifier: NCT00177255 - Active, not recruiting
  Cancer
  
• Foreshortened Esophagus and Its Surgical Therapy
  ClinicalTrials.gov Identifier: NCT00507377 - Active, not recruiting
  Gastroesophageal Reflux Disease; Hiatal Hernia
  
• Oxaliplatin, Fluorouracil, Radiation Therapy, and Surgery in Treating Patients With Stage II or Stage III Cancer of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00086996 - Recruiting
  Adenocarcinoma of the Esophagus; stage II esophageal cancer; stage III esophageal cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00021320 - Active, not recruiting
  stage 0 esophageal cancer; stage I esophageal cancer; stage II esophageal cancer; stage III esophageal cancer; ...
  
• The Effect of Nexium on Transmucosal Esophageal Leak
  ClinicalTrials.gov Identifier: NCT00216788 - Not yet recruiting
  Reflux; Esophagitis; Barrett''s Esophagus
  
• Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus
  ClinicalTrials.gov Identifier: NCT00239200 - Recruiting
  Metastatic or Recurrent Squamous Cell Carcinoma of the Esophagus
  
• Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule
  ClinicalTrials.gov Identifier: NCT00579410 - Active, not recruiting
  Esophagitis; Inflammation; Gastritis; Abdominal Pain; Heartburn
  
• Esomeprazole With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett's Metaplasia
  ClinicalTrials.gov Identifier: NCT00357682 - Recruiting
  Esophageal Cancer; Precancerous/Nonmalignant Condition
  
• Computed Tomography in Detecting Movement of the Esophagus in Patients Undergoing Radiation Therapy to the Chest
  ClinicalTrials.gov Identifier: NCT00433524 - Active, not recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00193141 - Active, not recruiting
  Esophagus Cancer
  
• Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00002883 - Active, not recruiting
  stage I gastric cancer; stage II gastric cancer; stage I esophageal cancer; stage II esophageal cancer; adenocarcinoma of the stomach; ...
  
• Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus
  ClinicalTrials.gov Identifier: NCT00003076 - Completed
  prevention of esophageal cancer; Esophageal Cancer
  
• Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00054457 - Active, not recruiting
  adenocarcinoma of the stomach; Adenocarcinoma of the Esophagus; stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; ...
  
• Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00020787 - Active, not recruiting
  stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
  
• Nitrocamptothecin in Treating Patients With Locally Advanced or Metastatic Stomach Cancer That Cannot Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00005876 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
  
• Combination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00006081 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; stage IV gastric cancer; ...
  
• BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy
  ClinicalTrials.gov Identifier: NCT00017043 - Active, not recruiting
  stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; stage IV gastric cancer; recurrent esophageal cancer; ...
  
• Combination Chemotherapy Followed by Surgery and Intraperitoneal Chemotherapy in Treating Patients With Locally Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00006038 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; stage IV gastric cancer; ...
  
• Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00004236 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; recurrent gastric cancer; ...
  
• Combination Chemotherapy in Treating Patients With Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00041262 - Recruiting
  stage II esophageal cancer; stage III esophageal cancer; Adenocarcinoma of the Esophagus
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00002631 - Completed
  squamous cell carcinoma of the esophagus; stage III esophageal cancer; Adenocarcinoma of the Esophagus; stage I esophageal cancer; ...
  
• Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach
  ClinicalTrials.gov Identifier: NCT00020761 - Active, not recruiting
  stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; recurrent esophageal cancer; adenocarcinoma of the stomach; ...
  
• Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00318903 - Completed
  Esophageal Cancer; Cancer of the Esophagus; Esophagus Cancer; Esophageal Neoplasm; Cancer of Esophagus
  
• Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer.
  ClinicalTrials.gov Identifier: NCT00153881 - Recruiting
  Esophageal Neoplasm; Gastro-esophageal Neoplasm; Carcinoma of the Esophagus; Esophageal Cancer
  
• Oxaliplatin in Esophagus Cancer (Advanced) 1st Line
  ClinicalTrials.gov Identifier: NCT00259402 - Recruiting
  Esophageal Neoplasms
  
• Effect of Meal on Portal and Esophagus Variceal Pressure
  ClinicalTrials.gov Identifier: NCT00485290 - Recruiting
  Cirrhosis; Esophageal Varices
  
• Demographics and Findings of Upper Endoscopy Patients
  ClinicalTrials.gov Identifier: NCT00576992 - Recruiting
  Barrett Esophagus; Gastroesophageal Reflux
  
• Feasibility of Placing Bravo PH Capsule in Proximal Esophagus
  ClinicalTrials.gov Identifier: NCT00378898 - Recruiting
  Gastroesophageal Reflux Disease
  
• Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00411151 - Recruiting
  Adenocarcinoma of Stomach; Barret Esophagus
  
• Erlotinib in Treating Patients With Barrett Esophagus
  ClinicalTrials.gov Identifier: NCT00566800 - Recruiting
  Esophageal Cancer; Precancerous/Nonmalignant Condition
  
• HEARD (Long Term) Study – Histology of the Esophagus in Acid-Related Disease
  ClinicalTrials.gov Identifier: NCT00243724 - Recruiting
  Gastroesophageal Reflux; Heartburn; Dyspepsia
  
• Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia.
  ClinicalTrials.gov Identifier: NCT00193882 - Recruiting
  Esophagus Cancer
  
• Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00442507 - Recruiting
  Esophageal Neoplasms; Esophageal Diseases
  
• Comparison of Esophageal and Anorectal Manometry Catheters
  ClinicalTrials.gov Identifier: NCT00204763 - Recruiting
  Achalasia; Nutcracker Esophagus; Scleroderma; Esophageal Spasm; Fecal Incontinence
  
• Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)
  ClinicalTrials.gov Identifier: NCT00149266 - Active, not recruiting
  Gastric Neoplasm
  
• Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00201747 - Active, not recruiting
  Esophageal Cancer; Esophagus Cancer; Cancer of Stomach; Stomach Cancer
  
• Phase I/II Study of Panitumumab, Capecitabine and Oxaliplatin w EBRT for Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00578071 - Recruiting
  Cancer of the Esophagus; Locally Advanced; Unresectable
  
• Irinotecan in Treating Patients With Esophageal or Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00003748 - Active, not recruiting
  stage III gastric cancer; stage III esophageal cancer; stage IV esophageal cancer; Adenocarcinoma of the Esophagus; stage II gastric cancer; ...
  
• TRIAD Burden of Illness Mucositis Study
  ClinicalTrials.gov Identifier: NCT00336609 - Recruiting
  Gastrointestinal Mucositis (Defined as Mucositis Involving the Mouth, Esophagus, or Small Intestine)
  
• Esomeprazole With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
  ClinicalTrials.gov Identifier: NCT00474903 - Recruiting
  Esophageal Cancer; Precancerous/Nonmalignant Condition
  
• Erlotinib in Treating Patients With Advanced Esophageal Cancer or Stomach Cancer
  ClinicalTrials.gov Identifier: NCT00045526 - Completed
  Adenocarcinoma of the Esophagus; recurrent esophageal cancer; squamous cell carcinoma of the esophagus; stage III esophageal cancer; ...
  
• Three Field Radical Esophagectomy Versus Two Field Esophagectomy - a Prospective Trial
  ClinicalTrials.gov Identifier: NCT00193817 - Recruiting
  Cancer of Esophagus
  
• Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00493025 - Recruiting
  Esophageal Cancer
  
• Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus
  ClinicalTrials.gov Identifier: NCT00165191 - Completed
  Adenocarcinoma of Stomach; Adenocarcinoma of GE Junction; Adenocarcinoma of Esophagus
  
• Oxaliplatin, Fluorouracil, Erlotinib, and Radiation Therapy Before Surgery and Erlotinib After Surgery in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00499564 - Recruiting
  Esophageal Cancer; Gastric Cancer
  
• Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction
  ClinicalTrials.gov Identifier: NCT00061958 - Completed
  Adenocarcinoma of the Esophagus; stage III esophageal cancer; stage IV esophageal cancer